Literature DB >> 3503544

Cyclosporine A inhibits calcemic hormone-induced bone resorption in vitro.

P J Stewart1, O C Green, P H Stern.   

Abstract

We have investigated the in vitro effects of cyclosporine (CsA), a potent immunosuppressive agent, on bone resorption induced by calcemic hormones. CsA inhibited parathyroid hormone (PTH), prostaglandin E2, 1,25-dihydroxy vitamin D3 (1,25(OH)2D3), and osteoclast-activating factor induced resorption of fetal rat limb bones in a dose-dependent manner. Established ongoing resorptive activity in bone was also inhibited by CsA. The CsA inhibition of bone resorption could be partially surmounted by higher concentrations of PTH and 1,25(OH)2D3. The inhibitory effects of CsA on limb bone resorption were reversible. Neither protein nor DNA synthesis were inhibited by treatment of limb bones with CsA. Thus, the inhibitory effect of this agent on bone resorption is not a cytotoxic one. These data could suggest that the induction of bone resorption by the calcemic hormones involves an immune cell derived mediator such as a lymphokine.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3503544     DOI: 10.1002/jbmr.5650010307

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  15 in total

1.  High-turnover osteoporosis is induced by cyclosporin A in rats.

Authors:  Chie Wada; Masatoshi Kataoka; Hiroyuki Seto; Noriko Hayashi; Jun-ichi Kido; Yasuo Shinohara; Toshihiko Nagata
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

2.  Cyclosporin A: friend or foe?

Authors:  S Epstein
Journal:  Calcif Tissue Int       Date:  1991-10       Impact factor: 4.333

3.  Effects of cyclosporins and transforming growth factor beta 1 on thyroid hormone action in cultured fetal rat limb bones.

Authors:  P Lakatos; P H Stern
Journal:  Calcif Tissue Int       Date:  1992-02       Impact factor: 4.333

Review 4.  International consensus recommendations on cyclosporin use in rheumatoid arthritis.

Authors:  P Tugwell
Journal:  Drugs       Date:  1995       Impact factor: 9.546

5.  1,25 Dihydroxyvitamin D3 modifies cyclosporine-induced bone loss.

Authors:  S Epstein; M Schlosberg; M Fallon; S Thomas; C Movsowitz; F Ismail
Journal:  Calcif Tissue Int       Date:  1990-09       Impact factor: 4.333

6.  Continuing loss of vertebral mineral density in renal transplant recipients.

Authors:  B Bagni; P Gilli; A Cavallini; I Bagni; M C Marzola; C Orzincolo; H W Wahner
Journal:  Eur J Nucl Med       Date:  1994-02

7.  Bone loss after cardiac transplantation: effects of calcium, calcidiol and monofluorophosphate.

Authors:  E Meys; F Terreaux-Duvert; T Beaume-Six; G Dureau; P J Meunier
Journal:  Osteoporos Int       Date:  1993-12       Impact factor: 4.507

8.  Effects of cyclosporin A on rat osteoblasts (ROS 17/2.8 cells) in vitro.

Authors:  L K McCauley; T J Rosol; C C Capen
Journal:  Calcif Tissue Int       Date:  1992-10       Impact factor: 4.333

9.  Effects of cyclosporine A on chick osteoclasts in vitro.

Authors:  M H Chowdhury; V Shen; D W Dempster
Journal:  Calcif Tissue Int       Date:  1991-10       Impact factor: 4.333

Review 10.  Mechanism of action of cyclosporin in rheumatoid arthritis.

Authors:  J Bentin
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.